Combinatorial control of suicide gene expression by tissue-specific promoter and microrna regulation for cancer therapy

Molecular Therapy

Volumn 17, Issue 12, 2009, Pages 2058-2066

  Wu, Chunxiao ^a   Lin, Jiakai ^a   Hong, Michelle ^a,b   Choudhury, Yukti ^a   Balani, Poonam ^a   Leung, Doreen ^a   Dang, Lam H ^a,b   Zhao, Ying ^a   Zeng, Jieming ^a   Wang, Shu ^a,b  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MICRORNA; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTROCYTE; BACULOVIRUS EXPRESSION SYSTEM; CANCER CELL CULTURE; CANCER GENE THERAPY; CONTROLLED STUDY; DRUG SPECIFICITY; DRUG TARGETING; EMBRYO; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; PROMOTER REGION; RNA SEQUENCE; SUICIDE GENE THERAPY; TISSUE SPECIFICITY; TRANSGENE; TUMOR XENOGRAFT;

ANIMALS; ASTROCYTES; BACULOVIRIDAE; BRAIN NEOPLASMS; CELLS, CULTURED; DRUG THERAPY, COMBINATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; PROMOTER REGIONS, GENETIC; THYMIDINE KINASE; TRANSGENES;

SIMPLEXVIRUS;

EID: 73849105202     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.225     Document Type: Article

References (42)

1. Harrington, KJ, Linardakis, E and Vile, RG (2000). Transcriptional control: an essential component of cancer gene therapy strategies? Adv Drug Deliv Rev 44: 167-184.
2. Robson, T and Hirst, DG (2003). Transcriptional targeting in cancer gene therapy. J Biomed Biotechnol 2003: 110-137.
3. Saukkonen, K and Hemminki, A (2004). Tissue-specific promoters for cancer gene therapy. Expert Opin Biol Ther 4: 683-696. (Pubitemid 38667814)
4. Yang, J, Su, AI and Li, WH (2005). Gene expression evolves faster in narrowly than in broadly expressed mammalian genes. Mol Biol Evol 22: 2113-2118.
5. Birney, E, Stamatoyannopoulos, JA, Dutta, A, Guigó, R, Gingeras, TR, Margulies, EH et al. (2007). Identifcation and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816.
6. Stoff-Khalili, MA, Rivera, AA, Nedeljkovic-Kurepa, A, DeBenedetti, A, Li, XL, Odaka, Y et al. (2008). Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control. Breast Cancer Res Treat 108: 43-55.
7. Filipowicz, W, Bhattacharyya, SN and Sonenberg, N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114.
8. John, B, Enright, AJ, Aravin, A, Tuschl, T, Sander, C and Marks, DS (2004). Human MicroRNA targets. PLoS Biol 2: e363.
9. Lewis, BP, Burge, CB and Bartel, DP (2005). Conserved seed pairing, often fanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
10. Brown, BD, Venneri, MA, Zingale, A, Sergi Sergi, L and Naldini, L (2006). Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat Med 12: 585-591.
11. Brown, BD, Gentner, B, Cantore, A, Colleoni, S, Amendola, M, Zingale, A et al. (2007). Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 25: 1457-1467.
12. Ciafrè, SA, Galardi, S, Mangiola, A, Ferracin, M, Liu, CG, Sabatino, G et al. (2005). Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351-1358.
13. Saito, Y, Liang, G, Egger, G, Friedman, JM, Chuang, JC, Coetzee, GA et al. (2006). specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9: 435-443.
14. Landgraf, P, Rusu, M, Sheridan, R, Sewer, A, Iovino, N, Aravin, A et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
15. Wang, CY and Wang, S (2006). Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter. Gene Ther 13: 1447-1456.
16. Wang, CY, Li, F, Yang, Y, Guo, HY, Wu, CX and Wang, S (2006). Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy. Cancer Res 66: 5798-5806.
17. Griffths-Jones, S, Saini, HK, van Dongen, S and Enright, AJ (2008). miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-D158.
18. Chen, J, Bezdek, T, Chang, J, Kherzai, AW, Willingham, T, Azzara, M et al. (1998). A glial-specific, repressible, adenovirus vector for brain tumor gene therapy. Cancer Res 58: 3504-3507.
19. McKie, EA, Graham, DI and Brown, SM (1998). Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector-potential glioblastoma targeting. Gene Ther 5: 440-450.
20. Horst, M, Brouwer, E, Verwijnen, S, Rodijk, M, de Jong, M, Hoeben, R et al. (2007). Targeting malignant gliomas with a glial fbrillary acidic protein (GFAP)-selective oncolytic adenovirus. J Gene Med 9: 1071-1079.
21. Herraiz, M, Beraza, N, Solano, A, Sangro, B, Montoya, J, Qian, C et al. (2003). Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion. Hum Gene Ther 14: 463-472.
22. van der Eb, MM, Geutskens, SB, van Kuilenburg, AB, van Lenthe, H, van Dierendonck, JH, Kuppen, PJ et al. (2003). Ganciclovir nucleotides accumulate in mitochondria of rat liver cells expressing the herpes simplex virus thymidine kinase gene. J Gene Med 5: 1018-1027.
23. Maron, A, Havaux, N, Le Roux, A, Knoops, B, Perricaudet, M and Octave, JN (1997). Differential toxicity of ganciclovir for rat neurons and astrocytes in primary culture following adenovirus-mediated transfer of the HSVtk gene. Gene Ther 4: 25-31.
24. Bush, TG, Savidge, TC, Freeman, TC, Cox, HJ, Campbell, EA, Mucke, L et al. (1998). Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 93: 189-201.
25. Bushati, N and Cohen, SM (2007). microRNA functions. Annu Rev Cell Dev Biol 23: 175-205.
26. Kloosterman, WP and Plasterk, RH (2006). The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450.
27. Esquela-Kerscher, A and Slack, FJ (2006). Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
28. Rosenfeld, N, Aharonov, R, Meiri, E, Rosenwald, S, Spector, Y, Zepeniuk, M et al. (2008). MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26: 462-469.
29. Calin, GA, Sevignani, C, Dumitru, CD, Hyslop, T, Noch, E, Yendamuri, S et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004.
30. Lu, J, Getz, G, Miska, EA, Alvarez-Saavedra, E, Lamb, J, Peck, D et al. (2005). MicroRNA expression profles classify human cancers. Nature 435: 834-838.
31. Silber, J, Lim, DA, Petritsch, C, Persson, AI, Maunakea, AK, Yu, M et al. (2008). miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6: 14.
32. Godlewski, J, Nowicki, MO, Bronisz, A, Williams, S, Otsuki, A, Nuovo, G et al. (2008). Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68: 9125-9130.
33. Bartel, DP and Chen, CZ (2004). Micromanagers of gene expression: the potentially widespread infuence of metazoan microRNAs. Nat Rev Genet 5: 396-400.
34. Reinhart, BJ, Slack, FJ, Basson, M, Pasquinelli, AE, Bettinger, JC, Rougvie, AE et al. (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901-906.
35. Abrahante, JE, Daul, AL, Li, M, Volk, ML, Tennessen, JM, Miller, EA et al. (2003). The Caenorhabditis elegans hunchback-like gene lin-57/hbl-1 controls developmental time and is regulated by microRNAs. Dev Cell 4: 625-637.
36. Lin, SY, Johnson, SM, Abraham, M, Vella, MC, Pasquinelli, A, Gamberi, C et al. (2003). The C elegans hunchback homolog, hbl-1, controls temporal patterning and is a probable microRNA target. Dev Cell 4: 639-650.
37. Sempere, LF, Freemantle, S, Pitha-Rowe, I, Moss, E, Dmitrovsky, E and Ambros, V (2004). Expression profling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5: R13.
38. Doench, JG, Petersen, CP and Sharp, PA (2003). siRNAs can function as miRNAs. Genes Dev 17: 438-442.
39. Zeng, J, Du, J, Zhao, Y, Palanisamy, N and Wang, S (2007). Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells. Stem Cells 25: 1055-1061.
40. Griffths-Jones, S, Grocock, RJ, van Dongen, S, Bateman, A and Enright, AJ (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-D144.
41. Shi, R and Chiang, VL (2005). Facile means for quantifying microRNA expression by real-time PCR. BioTechniques 39: 519-525.
42. Balani, P, Boulaire, J, Zhao, Y, Zeng, J, Lin, J and Wang, S (2009). High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment. Mol Ther 17: 1003-1011.